ObsEva SA to Attend Baird Global Healthcare Conference and Rodman & Renshaw Annual Global Investment Conference in NYC
(Thomson Reuters ONE) -
ObsEva SA /
ObsEva SA to Attend Baird Global Healthcare Conference and Rodman & Renshaw
Annual Global Investment Conference in NYC
. Processed and transmitted by Nasdaq Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Geneva, Switzerland and Boston, MA - 30 August, 2017 - ObsEva SA (NASDAQ: OBSV),
a clinical-stage biopharmaceutical company focused on the development and
commercialization of novel therapeutics for serious conditions that compromise a
woman's reproductive health and pregnancy, today announced that Company
Management will be presenting at the below conferences and also hosting one on
one meetings with investors.
* The Baird 2017 Global Healthcare Conference taking place in New York, at the
InterContinental New York Barclay, on September 6-7, 2017. Company
Management will be presenting on Wednesday September 6, 2017, at 2:00 p.m.
Eastern Time.
* The Rodman & Renshaw 19(th) Annual Global Investment Conference taking place
in New York, at the Lotte New York Palace, on September 10-12, 2017. Company
Management will be presenting on Tuesday September 12, 2017, at 10:25 a.m.
Eastern Time.
About ObsEva
ObsEva is a clinical-stage biopharmaceutical company focused on the clinical
development and commercialization of novel therapeutics for serious conditions
that compromise a woman's reproductive health and pregnancy. Through strategic
in-licensing and disciplined drug development, ObsEva has established a late-
stage clinical pipeline with development programs focused on treating
endometriosis, uterine fibroids, preterm labor and improving ART outcomes.
ObsEva is listed on The NASDAQ Global Select Market and is trading under the
ticker symbol "OBSV". For more information, please visit www.ObsEva.com.
Cautionary Note Regarding Forward Looking Statements
Any statements contained in this press release that do not describe historical
facts may constitute forward-looking statements as that term is defined in the
Private Securities Litigation Reform Act of 1995. These statements may be
identified by words such as "believe", "expect", "may", "plan," "potential,"
"will," and similar expressions, and are based on ObsEva's current beliefs and
expectations. These forward-looking statements include expectations regarding
the clinical development of ObsEva's product candidates and the timing of
enrollment in and data from clinical trials. These statements involve risks and
uncertainties that could cause actual results to differ materially from those
reflected in such statements. Risks and uncertainties that may cause actual
results to differ materially include uncertainties inherent in the conduct of
clinical trials, ObsEva's reliance on third parties over which it may not always
have full control, and other risks and uncertainties that are described in the
Risk Factors section of ObsEva's Annual Report on Form 20-F for the year ended
December 31, 2016, and other filings ObsEva makes with the SEC. These documents
are available on the Investors page of ObsEva's website at
http://www.obseva.com. Any forward-looking statements speak only as of the date
of this press release and are based on information available to ObsEva as of the
date of this release, and ObsEva assumes no obligation to, and does not intend
to, update any forward-looking statements, whether as a result of new
information, future events or otherwise.
###
Media Contact:
Liz Bryan
Spectrum Science
lbryan(at)spectrumscience.com
202-955-6222 x2526
CEO Office contact:
Delphine Renaud
delphine.renaud(at)obseva.ch
+41 22 552 1550
Investor Contact:
Mario Corso
Senior Director, Investor Relations
mario.corso(at)obseva.com
781-366-5726
Press Release:
http://hugin.info/157613/R/2129870/813669.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ObsEva SA via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 30.08.2017 - 13:00 Uhr
Sprache: Deutsch
News-ID 558288
Anzahl Zeichen: 4842
contact information:
Town:
Plan-les-Ouates
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 210 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ObsEva SA to Attend Baird Global Healthcare Conference and Rodman & Renshaw Annual Global Investment Conference in NYC"
steht unter der journalistisch-redaktionellen Verantwortung von
ObsEva SA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
